These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7119781)

  • 1. Artifactual increases in the concentration of free GABA in samples of human cerebrospinal fluid are due to degradation of homocarnosine.
    Grove J; Schechter PJ; Tell G; Rumbach L; Marescaux C; Warter JM; Koch-Weser J
    J Neurochem; 1982 Oct; 39(4):1061-5. PubMed ID: 7119781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration gradients of free and total gamma-aminobutyric acid and homocarnosine in human CSF: comparison of suboccipital and lumbar sampling.
    Grove J; Schechter PJ; Hanke NF; de Smet Y; Agid Y; Tell G; Koch-Weser J
    J Neurochem; 1982 Dec; 39(6):1618-22. PubMed ID: 7142991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total GABA and homocarnosine in CSF as indices of brain GABA concentrations.
    Palfreyman MG; Huot S; Grove J
    Neurosci Lett; 1983 Feb; 35(2):161-6. PubMed ID: 6856194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea.
    Bonnet AM; Tell G; Schechter PJ; Grove J; Saint-Hilaire MH; De Smet Y; Agid Y
    Mov Disord; 1987; 2(2):117-23. PubMed ID: 2973560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of single doses of vigabatrin on CSF concentrations of GABA, homocarnosine, homovanillic acid and 5-hydroxyindoleacetic acid in patients with complex partial epilepsy.
    Menachem EB; Persson LI; Schechter PJ; Haegele KD; Huebert N; Hardenberg J; Dahlgren L; Mumford JP
    Epilepsy Res; 1988; 2(2):96-101. PubMed ID: 3143561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Concentration of free amino acids and homocarnosine dipeptide in the cerebrospinal fluid of children with hydrocephalus].
    Bondarenko TI; Makletsova MG; Sukhomovskiĭ BI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(10):1484-8. PubMed ID: 6659780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of total gamma-aminobutyric acid (GABA), free GABA and homocarnosine in cerebrospinal fluid of epileptic patients before and during gamma-vinyl-GABA (vigabatrin) treatment.
    Pitkänen A; Matilainen R; Ruutiainen T; Riekkinen P
    J Neurol Sci; 1988 Dec; 88(1-3):83-93. PubMed ID: 3225631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid parameters in healthy volunteers during serial lumbar punctures.
    Ben Menachem E; Persson L; Schechter PJ; Haegele KD; Huebert N; Hardenberg J
    J Neurochem; 1989 Feb; 52(2):632-5. PubMed ID: 2463340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocarnosine levels in cerebrospinal fluid of patients with infantile spasms under ACTH therapy.
    Ohtsuka C; Sato Y; Takahashi H
    Brain Dev; 1983; 5(5):464-8. PubMed ID: 6318586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased gamma-aminobutyric acid (GABA), homocarnosine and beta-alanine in cerebrospinal fluid of patients treated with gamma-vinyl GABA (4-amino-hex-5-enoic acid).
    Grove J; Schechter PJ; Tell G; Koch-Weser J; Sjoerdsma A; Warter JM; Marescaux C; Rumbach L
    Life Sci; 1981 May; 28(21):2431-9. PubMed ID: 6789022
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on homocarnosine in cerebrospinal fluid in infancy and childhood. Part II. Homocarnosine levels in cerebrospinal fluid from children with epilepsy, febrile convulsion or meningitis.
    Takahashi H
    Brain Dev; 1981; 3(3):263-70. PubMed ID: 7283086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on homocarnosine in cerebrospinal fluid in infancy and childhood. Part I. Homocarnosine level in cerebrospinal fluid of normal infants and children.
    Takahashi H
    Brain Dev; 1981; 3(3):255-61. PubMed ID: 7283085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-term vigabatrin therapy on selected neurotransmitter concentrations in cerebrospinal fluid.
    Ben-Menachem E; Persson LI; Mumford J; Haegele KD; Huebert N
    J Child Neurol; 1991; Suppl 2():S11-6. PubMed ID: 1719063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of GABA levels in CSF under various conditions of storage.
    Grossman MH; Hare TA; Manyam NV; Glaeser BS; Wood JH
    Brain Res; 1980 Jan; 182(1):99-106. PubMed ID: 7350995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human CSF GABA concentrations: revised downward for controls, but not decreased in Huntington's chorea.
    Perry TL; Hansen S; Wall RA; Gauthier SG
    J Neurochem; 1982 Mar; 38(3):766-73. PubMed ID: 6460090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel, quantitative assay for homocarnosine in cerebrospinal fluid using stable-isotope dilution liquid chromatography-tandem mass spectrometry.
    Jansen EE; Gibson KM; Shigematsu Y; Jakobs C; Verhoeven NM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(2):196-200. PubMed ID: 16309980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary GABA induces endogenous synthesis of a novel imidazole peptide homocarnosine in mouse skeletal muscles.
    Kumrungsee T; Arima T; Sato K; Komaru T; Sato M; Oishi Y; Egusa A; Yanaka N
    Amino Acids; 2020 May; 52(5):743-753. PubMed ID: 32361909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vigabatrin increases human brain homocarnosine and improves seizure control.
    Petroff OA; Mattson RH; Behar KL; Hyder F; Rothman DL
    Ann Neurol; 1998 Dec; 44(6):948-52. PubMed ID: 9851440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory and excitatory amino acids in cerebrospinal fluid of chronic epileptic patients.
    Pitkänen A; Matilainen R; Halonen T; Kutvonen R; Hartikainen P; Riekkinen P
    J Neural Transm; 1989; 76(3):221-30. PubMed ID: 2499662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical amelioration.
    Tell G; Böhlen P; Schechter PJ; Koch-Weser J; Agid Y; Bonnet AM; Coquillat G; Chazot G; Fischer C
    Neurology; 1981 Feb; 31(2):207-11. PubMed ID: 6258106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.